| Human papillomavirus is more prevalent in first trimester spontaneously aborted products of conception compared to elective specimens PL Hermonat, L Han, PJ Wendel, JG Quirk, S Stern, CL Lowery, ... Virus genes 14, 13-17, 1997 | 166 | 1997 |
| Cost-effectiveness of omalizumab for uncontrolled allergic asthma in the Netherlands F van Nooten, S Stern, GJ Braunstahl, C Thompson, M Groot, RE Brown Journal of Medical Economics 16 (3), 342-348, 2013 | 51 | 2013 |
| Lenalidomide for multiple myeloma: cost-effectiveness in patients with one prior therapy in England and Wales RE Brown, S Stern, S Dhanasiri, S Schey The European Journal of Health Economics 14, 507-514, 2013 | 43 | 2013 |
| Potential cost saving of Epoetin alfa in elective hip or knee surgery due to reduction in blood transfusions and their side effects: a discrete-event simulation model J Tomeczkowski, S Stern, A Müller, C von Heymann PLoS One 8 (9), e72949, 2013 | 24 | 2013 |
| Outcomes and costs of remote patient monitoring among patients with implanted cardiac defibrillators: an economic model based on the PREDICT RM database JP Hummel, RJ Leipold, SL Amorosi, H Bao, KA Deger, PW Jones, ... Journal of Cardiovascular Electrophysiology 30 (7), 1066-1077, 2019 | 20 | 2019 |
| A new framework for evaluating the health impacts of treatment for Gaucher disease type 1 ML Ganz, S Stern, A Ward, L Nalysnyk, M Selzer, A Hamed, N Weinreb Orphanet Journal of Rare Diseases 12, 1-9, 2017 | 13 | 2017 |
| Incidence of mental health conditions by seizure control among adults with epilepsy in the United States VF Schabert, S Stern, L Ferrari, CT Wade, RJ Willke, WA Hauser Epilepsy & Behavior 134, 108865, 2022 | 6 | 2022 |
| Cost–effectiveness of a FISH assay for the diagnosis of melanoma in the USA AR Kansal, AJ Shaul, S Stern, K Busam, CA Doucet, DB Chalfin Expert review of pharmacoeconomics & outcomes research 13 (3), 371-380, 2013 | 4 | 2013 |
| Sustainability of seizure reduction and seizure control with adjunctive cenobamate: Post hoc analysis of a phase 3, open‐label study DG Vossler, WE Rosenfeld, S Stern, CT Wade, L Ferrari, WT Kerr, ... Epilepsia 64 (10), 2644-2652, 2023 | 3 | 2023 |
| Cost-effectiveness of golimumab for the treatment of patients with moderate-to-severe ulcerative colitis in Quebec using a patient level state transition microsimulation S Stern, AJ Ward, C Saint-Laurent Thibault, F Camacho, E Rahme, ... Journal of medical economics 21 (1), 27-37, 2018 | 3 | 2018 |
| Economic modeling of new stent platforms to evaluate cost effectiveness: analysis of the TAXUS Liberte versus TAXUS express stents MA Turco, AR Kansal, S Stern, SL Amorosi, PL Underwood, ... Journal of Interventional Cardiology 25 (4), 353-363, 2012 | 3 | 2012 |
| Cost-effectiveness of lenalidomide in multiple myeloma patients with 1 prior therapy in England and Wales S Schey, S Stern, S Dhanasiri, R Brown Blood 118 (21), 4181, 2011 | 3 | 2011 |
| Cognitive and psychiatric adverse events during adjunctive cenobamate treatment in phase 2 and phase 3 clinical studies GL Krauss, SS Chung, L Ferrari, S Stern, WE Rosenfeld Epilepsy & Behavior 151, 109605, 2024 | 2 | 2024 |
| Real-world analysis of retention on cenobamate in patients with epilepsy in the United States S Stern, M Weingarten, S Mandapati, L Ferrari, CT Wade Epilepsy Research 197, 107207, 2023 | 2 | 2023 |
| Simulation study on differences in Alzheimer Disease (AD) Cooperative Study–Preclinical Alzheimer Cognitive Composite (ADCS-PACC) Based on Long-term Clinical Outcomes (P5. 193) A Kansal, S Stern, A Keenan Neurology 90 (15_supplement), P5. 193, 2018 | 2 | 2018 |
| Health State Utilities for Gaucher Disease Type 1 M Ganz, S Stern, A Ward, M Selzer, L Nalysnyk, A Hamed, N Weinreb ISPOR Europe 18, 2015 | 2 | 2015 |
| Safety and Efficacy of Cenobamate for the Treatment of Focal Seizures in Older Patients (P4-1.002) R O’Dwyer, S Stern, C Wade, A Guggilam, WE Rosenfeld Neurology 100 (17_supplement_2), 1897, 2023 | 1 | 2023 |
| PND32 EVALUATION OF GLOBAL IMPROVEMENT AND LIFETIME COSTS OF TREATING TARDIVE DYSKINESIA SHOWS TREATMENT WITH VALBENAZINE DOMINATES DEUTETRABENAZINE M Ganz, S Stern, A Chavan, M Serbin, C Yonan Value in Health 22, S275, 2019 | 1 | 2019 |
| Potential clinical benefits and cost savings associated with inclusion of apixaban in the formulary for treatment of patients with venous thromboembolism M Hamilton, R Leipold, D Rublee, S Stern, D Gabriel, T Gosden, A Cohen European heart journal 36, 225-225, 2015 | 1 | 2015 |
| Creating Patient Profile in Individual Simulations: A Comparison of Approaches S Stern, F Pan Value in Health 17 (7), A555-A556, 2014 | 1 | 2014 |
